ID

35124

Beschreibung

Study ID: 101468/205 Clinical Study ID: 101468/205 Study Title:A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) in Patients with Restless Legs Syndrome Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00197080 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome

Stichworte

  1. 18.02.19 18.02.19 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

18. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Efficacy and Safety of Ropinirole XR (Extended Release) in Patients with Restless Legs Syndrome NCT00197080

Week 12/ Early Withdrawal - Vital Signs; Rebound Question; Follow-Up - Vital Signs; Subject's Food Intake

Administrative
Beschreibung

Administrative

Alias
UMLS CUI-1
C1320722
Subject Identifier
Beschreibung

Subject Identifier

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
Week 12/ Early Withdrawal - Vital Signs
Beschreibung

Week 12/ Early Withdrawal - Vital Signs

Alias
UMLS CUI-1
C0518766
Systolic Blood Pressure
Beschreibung

Systolic Blood Pressure

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Diastolic Blood Pressure
Beschreibung

Diastolic Blood Pressure

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Subject position
Beschreibung

Subject position

Datentyp

integer

Alias
UMLS CUI [1]
C1262869
Weight
Beschreibung

Weight

Datentyp

float

Maßeinheiten
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Heart Rate
Beschreibung

Heart Rate

Datentyp

integer

Maßeinheiten
  • beats/min
Alias
UMLS CUI [1]
C0018810
beats/min
Rebound Question
Beschreibung

Rebound Question

Alias
UMLS CUI-1
C0549262
UMLS CUI-2
C1522634
During the last week of treatment, has the subject experienced symptoms of rebound the morning after taking their dose of investigational product (i.e., rebound defined as a re-emergence of RLS symptoms in the early morning the day after taking the dose of RLS medication)?
Beschreibung

If Yes, record in the Adverse Event section of the CRF.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0549262
UMLS CUI [1,2]
C1457887
UMLS CUI [1,3]
C0304229
UMLS CUI [1,4]
C0035258
Follow-Up - Vital Signs
Beschreibung

Follow-Up - Vital Signs

Alias
UMLS CUI-1
C0518766
Systolic Blood Pressure
Beschreibung

Systolic Blood Pressure

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Diastolic Blood Pressure
Beschreibung

Diastolic Blood Pressure

Datentyp

integer

Maßeinheiten
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Subject position
Beschreibung

Subject position

Datentyp

integer

Alias
UMLS CUI [1]
C1262869
Heart Rate
Beschreibung

Heart Rate

Datentyp

integer

Maßeinheiten
  • beats/min
Alias
UMLS CUI [1]
C0018810
beats/min
Subject's Food Intake
Beschreibung

Subject's Food Intake

Alias
UMLS CUI-1
C0518037
Date and time of finishing last meal prior to the Follow-Up Visit:
Beschreibung

Note: ECG measures should be taken two or more hours after a meal.

Datentyp

datetime

Alias
UMLS CUI [1]
C0578574

Ähnliche Modelle

Week 12/ Early Withdrawal - Vital Signs; Rebound Question; Follow-Up - Vital Signs; Subject's Food Intake

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
Week 12/ Early Withdrawal - Vital Signs
C0518766 (UMLS CUI-1)
Systolic Blood Pressure
Item
Systolic Blood Pressure
integer
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
integer
C0428883 (UMLS CUI [1])
Item
Subject position
integer
C1262869 (UMLS CUI [1])
Code List
Subject position
CL Item
Supine (1)
CL Item
Sitting (2)
CL Item
Standing (3)
CL Item
Semi-supine (4)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Heart Rate
Item
Heart Rate
integer
C0018810 (UMLS CUI [1])
Item Group
Rebound Question
C0549262 (UMLS CUI-1)
C1522634 (UMLS CUI-2)
During the last week of treatment, has the subject experienced symptoms of rebound the morning after taking their dose of investigational product
Item
During the last week of treatment, has the subject experienced symptoms of rebound the morning after taking their dose of investigational product (i.e., rebound defined as a re-emergence of RLS symptoms in the early morning the day after taking the dose of RLS medication)?
boolean
C0549262 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0035258 (UMLS CUI [1,4])
Item Group
Follow-Up - Vital Signs
C0518766 (UMLS CUI-1)
Systolic Blood Pressure
Item
Systolic Blood Pressure
integer
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
integer
C0428883 (UMLS CUI [1])
Item
Subject position
integer
C1262869 (UMLS CUI [1])
Code List
Subject position
CL Item
Supine  (1)
CL Item
Sitting  (2)
CL Item
Standing  (3)
CL Item
Semi-supine (4)
Heart Rate
Item
Heart Rate
integer
C0018810 (UMLS CUI [1])
Item Group
Subject's Food Intake
C0518037 (UMLS CUI-1)
Date and time of finishing last meal prior to the Follow-Up Visit:
Item
Date and time of finishing last meal prior to the Follow-Up Visit:
datetime
C0578574 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video